Searchable abstracts of presentations at key conferences in endocrinology

ea0090oc9.1 | Oral Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Identification of adrenocortical masses malignancy and aggressivity through radiomics: a pilot study

Tucci Lorenzo , Vara Giulio , Improta Ilaria , Leo Antonio De , Selva Saverio , Balacchi Caterina , Santini Donatella , Mosconi Cristina , Vicennati Valentina , Pagotto Uberto , Dalmazi Guido Di

Background: Adrenal lipid poor adenoma (LPA) and adrenocortical cancer (ACC) may overlap in computerized tomography (CT). Radiomics recently emerged as new tool for malignant behavior identification.Aim: To assess radiomics utility for identification of ACC and LPA in adrenocortical masses with unenhanced (UE) CT scan attenuationā‰„10 Hounsfield Unit (HU).Methods: We retrospectively enrolled 50 patients, 38 radiologically defin...

ea0073pep11.4 | Presented ePosters 11: Adrenal and Cardiovascular Endocrinology | ECE2021

Computerized tomography texture analysis in pheochromocytoma: correlation with clinical, biochemical, and histopathological data

Di Dalmazi Guido , Vara Giulio , Leo Antonio De , Paccapelo Alexandro , Tucci Lorenzo , Vicennati Valentina , Selva Saverio , Balacchi Caterina , Santini Donatella , Minni Francesco , Pagotto Uberto , Golfieri Rita , Mosconi Cristina

Computerized tomography (CT) texture analysis (TA) provides a valuable amount of quantitative data on single voxels and their relationship in a target lesions, giving additional value to the CT scan. CTTA has been applied to several oncologic diseases. We aimed to correlate the data derived from CTTA of pheochromocytoma to clinical, biochemical and histopathological data in 30 consecutive patients. Pheochromocytoma was confirmed at histology. The CTTA was performed on unenhanc...

ea0081rc3.5 | Rapid Communications 3: Thyroid 1 | ECE2022

Impact of stimulated thyroglobulin and BRAF status in Stage I and ATA intermediate risk DTC

Basso Cristina , Colapinto Alessandra , Vicennati Valentina , Pagotto Uberto , Tallini Giovanni , De Leo Antonio , De Biase Dario , Lodi Rizzini Elisa , Cavicchi Ottavio , Nannini Margherita , Tabacchi Elena , Golemi Arber , Repaci Andrea

Introduction: There is no clear indication for radioiodine treatment (RAI) in patients affected by differentiated thyroid cancer (DTC) in Stage I and ATA intermediate risk, according to American Thyroid Association (ATA) guidelines.Purpose: Our aim is to evaluate whether integration of BRAF status and thyroglobulin TSH-stimulated at the time of RAI (A-HTg) could further improve accuracy of stratification, and therefore therapeutic management, in DTC pati...